{"created":"2023-06-19T08:41:49.974533+00:00","id":9418,"links":{},"metadata":{"_buckets":{"deposit":"76fcae34-3f90-4d36-bfe8-9bef52901b4c"},"_deposit":{"created_by":2,"id":"9418","owners":[2],"pid":{"revision_id":0,"type":"depid","value":"9418"},"status":"published"},"_oai":{"id":"oai:gunma-u.repo.nii.ac.jp:00009418","sets":["719:759"]},"author_link":["38813","38811","38812"],"item_2_alternative_title_18":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"C型肝炎に対する直接作用型抗ウイルス薬治療後の発がん、合併症、長期予後に関 する研究"}]},"item_2_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-03-23","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{}]}]},"item_2_date_granted_63":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2021-03-23"}]},"item_2_degree_grantor_61":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"群馬大学"}]}]},"item_2_degree_name_60":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_2_description_39":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"Thesis or Dissertation","subitem_description_type":"Other"}]},"item_2_description_5":{"attribute_name":"内容記述","attribute_value_mlt":[{"subitem_description":"学位記番号：医博甲1839　","subitem_description_type":"Other"}]},"item_2_dissertation_number_64":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"12301甲第1839号"}]},"item_2_full_name_2":{"attribute_name":"著者(ヨミ)","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"38812","nameIdentifierScheme":"WEKO"}],"names":[{"name":"カナヤマ, ユウキ"}]}]},"item_2_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"38813","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Kanayama, Yuki"}]}]},"item_2_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"群馬大学医学系研究科"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"金山, 雄樹"}],"nameIdentifiers":[{"nameIdentifier":"38811","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-06-15"}],"displaytype":"detail","filename":"m-k1839-1.pdf","filesize":[{"value":"937.3 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"論文要旨","url":"https://gunma-u.repo.nii.ac.jp/record/9418/files/m-k1839-1.pdf"},"version_id":"b3fbfd13-6d8a-4aba-89bb-2f20b0e82cd2"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-06-15"}],"displaytype":"detail","filename":"m-k1839-2.pdf","filesize":[{"value":"160.2 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"審査要旨","url":"https://gunma-u.repo.nii.ac.jp/record/9418/files/m-k1839-2.pdf"},"version_id":"7f65c368-5dfb-4249-b089-3252436a61d4"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"chronic hepatitis C","subitem_subject_scheme":"Other"},{"subitem_subject":"direct-acting antiviral","subitem_subject_scheme":"Other"},{"subitem_subject":"malignancies","subitem_subject_scheme":"Other"},{"subitem_subject":"autommune disease","subitem_subject_scheme":"Other"},{"subitem_subject":"prognosis","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"The incidence of malignancy, complications, and the prognosis after direct-acting antiviral therapy for chronic hepatitis C","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The incidence of malignancy, complications, and the prognosis after direct-acting antiviral therapy for chronic hepatitis C"}]},"item_type_id":"2","owner":"2","path":["759"],"pubdate":{"attribute_name":"公開日","attribute_value":"2021-06-15"},"publish_date":"2021-06-15","publish_status":"0","recid":"9418","relation_version_is_last":true,"title":["The incidence of malignancy, complications, and the prognosis after direct-acting antiviral therapy for chronic hepatitis C"],"weko_creator_id":"2","weko_shared_id":-1},"updated":"2023-06-19T10:02:10.215611+00:00"}